WeVote
Log In

Bill

Bill

HB 146

Licensed health care providers; to permit the dispensing of ivermectin by pharmacists without an individual prescription

2026 Regular Session Introduced by Phillip Rigsby

Alabama bill allows pharmacists to dispense ivermectin without individual prescriptions, removing physician oversight for an antiparasitic with limited evidence for off-label uses.

Filed
#health
0
WeVote Research Nonpartisan
Bill Summary · HB 146

Legislative bill overview

HB 146 would allow licensed pharmacists in Alabama to dispense ivermectin without requiring an individual prescription from a healthcare provider. The bill expands pharmacists' authority to distribute this medication independently, similar to how some states permit pharmacists to dispense certain other medications under their own judgment.

Why is this important

Ivermectin is an antiparasitic drug approved by the FDA for treating specific parasitic infections in humans. During the COVID-19 pandemic, ivermectin gained significant attention as an off-label treatment despite limited evidence of effectiveness against coronavirus. This bill's passage could affect medication access, healthcare costs, and public health messaging around proven versus unproven treatments.

Potential points of contention

  • Medical efficacy concerns: Ivermectin lacks robust clinical evidence for treating COVID-19 and many other conditions it's promoted for, raising questions about whether pharmacist-dispensing expands access to unproven treatments
  • Oversight and accountability: Removing prescription requirements eliminates physician oversight, potentially reducing medical evaluation of whether the drug is appropriate for individual patients
  • Public health implications: Easier access could increase off-label use and complicate public health efforts to direct patients toward evidence-based treatments for various conditions

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.